Afya (NASDAQ:AFYA) Issues Quarterly Earnings Results

Afya (NASDAQ:AFYA) announced its earnings results on Thursday. The company reported $0.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.36 by $0.05, FiscalAI reports. The business had revenue of $147.08 million during the quarter, compared to analyst estimates of $174.74 million. Afya had a return on equity of 18.45% and a net margin of 20.12%.

Afya Stock Down 2.7%

NASDAQ AFYA traded down $0.38 during trading hours on Thursday, reaching $13.50. 41,147 shares of the company’s stock traded hands, compared to its average volume of 112,773. Afya has a 52-week low of $13.00 and a 52-week high of $19.90. The company has a debt-to-equity ratio of 0.21, a current ratio of 0.98 and a quick ratio of 0.98. The firm has a market cap of $1.27 billion, a PE ratio of 9.71, a PEG ratio of 0.63 and a beta of 0.52. The firm has a 50-day simple moving average of $14.46 and a 200 day simple moving average of $14.79.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the stock. Zacks Research raised shares of Afya from a “strong sell” rating to a “hold” rating in a research report on Monday. Bank of America cut shares of Afya from a “buy” rating to a “neutral” rating and dropped their target price for the stock from $22.00 to $17.00 in a research report on Tuesday, February 24th. JPMorgan Chase & Co. restated a “neutral” rating and set a $22.00 price target (down from $24.50) on shares of Afya in a research note on Wednesday, January 7th. UBS Group restated a “neutral” rating and set a $16.00 price target (down from $18.00) on shares of Afya in a research note on Friday, January 16th. Finally, Sanford C. Bernstein raised Afya to a “market perform” rating in a report on Friday, January 16th. One analyst has rated the stock with a Buy rating and seven have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $17.30.

Hedge Funds Weigh In On Afya

Hedge funds have recently bought and sold shares of the business. XTX Topco Ltd purchased a new stake in Afya during the 4th quarter valued at $215,000. Mangrove Partners IM LLC purchased a new position in shares of Afya during the 4th quarter valued at about $197,000. State Street Corp boosted its position in shares of Afya by 25.8% in the fourth quarter. State Street Corp now owns 126,914 shares of the company’s stock worth $1,955,000 after purchasing an additional 26,005 shares during the period. Campbell & CO Investment Adviser LLC boosted its holdings in Afya by 45.3% in the 4th quarter. Campbell & CO Investment Adviser LLC now owns 39,683 shares of the company’s stock worth $612,000 after buying an additional 12,365 shares during the period. Finally, Daiwa Securities Group Inc. purchased a new stake in shares of Afya during the fourth quarter worth about $43,000. Hedge funds and other institutional investors own 88.02% of the company’s stock.

Afya Company Profile

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.